This will be our Alkaline Free Crypto Portfolio. This portfolio will be held for the long term, so you must manage your capital to deal with potential dips in the crypto market. We will not provide every entry in one post, as we believe in the power of dollar-cost averaging. Leverage is not allowed, this portfolio must be followed by a Spot wallet.
Our analysis will be provided with an approximate entry price and the name of the token. All the ideas provided must be taken with the same capital so that the performance is similar to the CryptoAlkaline portfolio.
You must divide your capital into entries of 2-5%. For example, a 10k bag will place entries of $200-$ 500, and in case of running out of money from the allocated capital, new entries must be taken with the same size.
It has been proven that the cryptocurrency market follows the same direction most of the time and that in this case, diversification does not eliminate the risk of losing money. However, we rely on diversification as a tool to increase our exposure to sporadic hikes in certain Altcoins.
Understand the risks involved in buying cryptocurrencies, and execute these activities legally according to the regulations of your country.
NEW ENTRY in Algorand (ALGO/USD // ALGO/USDT) ENTRY PRICE $ 0.885 NO LEVERAGE, NO TARGETS
Please read our "Free Crypto Portfolio Rules" before placing your positions.
From a technical view, Bitcoin is in a good place to start buying near the 30k psychological level, so we could anticipate the next Altcoin Rally buying Algorand near the support situation.
This token has a use case for instant payments with low commissions and rewards through staking. Several payment processors such as Visa & Mastercard have shown interest in this asset. This fact causes the $1 level to be detected as a good buying opportunity, as it is considered reasonable for a token that could be used to pay for goods and services.
After this purchase, our average entry in Algorand is @$0.972.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.